Publication

2019

Journal

• "Conferring extracellular matrix affinity enhances local therapeutic efficacy of anti-TNF-α antibody in a murine model of rheumatoid arthritis"
  Katsumata K, Ishihara J, Fukunaga K, Ishihara A, Yuba E, Budina E, Hubbell JA
  Arthritis Research and Therapy 21, 1-10 (2019).
• "Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy"
  Williford J-M*, Ishihara J*, Ishihara A, Mansurov A, Hosseinchi P, Marchell TM, Potin L, Swartz MA, Hubbell JA
  Science Advances 5, 1-15 (2019). DOI:10.1126/sciadv.aay1357
• "Targeting inflammatory sites through collagen affinity enhances the therapeutic efficacy of anti-inflammatory antibodies"
  Katsumata K, Ishihara J, Mansurov A, Ishihara A, Raczy MM, Yuba E, Hubbell JA
  Science Advances 5, 1-9 (2019). DOI:10.1126/sciadv.aay1971
• "Engineered collagen-binding serum albumin as a drug conjugate carrier for cancer therapy"
  Sasaki K*, Ishihara J*, Ishihara A, Miura R, Mansurov A, Fukunaga K, Hubbell JA
  Science Advances 5, 1-12 (2019). DOI:10.1126/sciadv.aaw6081
• "The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing"
  Ishihara J, Ishihara A, Starke RD, Peghaire CR, Smith KE, McKinnon TAJ, Tabata Y, Sasaki K, White MJV, Fukunaga K, Laffan MA, Lutolf MP, Randi AM, Hubbell JA
  Blood 133, 2559-2569 (2019). DOI:10.1182/blood.2019000510
• "Targeted antibody and cytokine cancer immunotherapies through collagen affinity"
  Ishihara J*, Ishihara A*, Sasaki K, Lee SS-Y, Williford J-M, Yasui M, Abe H, Potin L, Hosseinchi P, Fukunaga K, Raczy MM, Gray LT, Mansurov A, Katsumata K, Fukayama M, Kron SJ, Swartz MA, Hubbell JA
  Science Translational Medicine 11, 1-13 (2019). DOI:10.1126/scitranslmed.aau3259